Caradon Therapeutics, Inc.

Biotechnology company · Encinitas, California, United States

Caradon Therapeutics, Inc. is a biotechnology company headquartered in Encinitas, California, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $559,328 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Caradon Therapeutics at a glance

Typebiotechnology company
HeadquartersEncinitas, California, United States
Earliest incorporation on record2023
SEC CIK2108983

What does Caradon Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $559,328 sold (2026).

Frequently asked questions about Caradon Therapeutics

Where is Caradon Therapeutics headquartered?

Caradon Therapeutics, Inc. is headquartered in Encinitas, California, United States.

What does Caradon Therapeutics do?

Caradon Therapeutics, Inc. is a biotechnology company.

When was Caradon Therapeutics founded?

The earliest incorporation on record for Caradon Therapeutics, Inc. is in 2023, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences